gabapentin

Product NDC
71610-069
11-digit product format
716100069
Labeler code
71610
Product ID
71610-069_cef6341b-bae4-4e08-a609-1afef9307f2e
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
gabapentin
Dosage form
TABLET, FILM COATED
Route
ORAL
Labeler
Aphena Pharma Solutions - Tennessee, LLC
Application
ANDA077525
Marketing category
ANDA
Marketing start
2006-08-24
Substance
GABAPENTIN
Active strength
600 mg/1
Pharmacologic classes
Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]
NDC exclude flag
No
Listing certified through
2026-12-31
Current FDA listing
Yes

Additional Listing Data#

Finished product
Yes
Brand name base
gabapentin
Listing expiration
2026-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
GABAPENTIN600 mg/1

Harmonized Identifiers#

Field, Values table
FieldValues
Unii6CW7F3G59X
Rxcui310433

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
cdc2ae60-922e-452d-a42f-787fe4e2ed06Product name120250123
7059096a-4b9f-36c2-db50-bb5c723e6e9eProduct name220250114
fa3f0129-3502-889f-f424-3a37727959e7Product name920181206
77d89e4c-f57f-326d-d7aa-787f8eebbd2bProduct name120140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
71610-069-602021-03-22C16284748780-19d75b9d0-d603-f424-e053-dadaa90a57ceThese highlights do not include all the information needed to use GABAPENTIN safely and effectively. See full prescribing information for GABAPENTIN. GABAPENTIN capsules, for oral use GABAPENTIN tablets, for oral use Initial U.S. Approval: 1993
71610-069-802021-03-22C16284748780-19d75b9d0-d603-f424-e053-dadaa90a57ceThese highlights do not include all the information needed to use GABAPENTIN safely and effectively. See full prescribing information for GABAPENTIN. GABAPENTIN capsules, for oral use GABAPENTIN tablets, for oral use Initial U.S. Approval: 1993
71610-069-922021-03-22C16284748780-19d75b9d0-d603-f424-e053-dadaa90a57ceThese highlights do not include all the information needed to use GABAPENTIN safely and effectively. See full prescribing information for GABAPENTIN. GABAPENTIN capsules, for oral use GABAPENTIN tablets, for oral use Initial U.S. Approval: 1993
71610-069-602020-01-31C16284748780-19d75b9d0-d603-f424-e053-dadaa90a57ceThese highlights do not include all the information needed to use GABAPENTIN safely and effectively. See full prescribing information for GABAPENTIN. GABAPENTIN capsules, for oral use GABAPENTIN tablets, for oral use Initial U.S. Approval: 1993
71610-069-802020-01-31C16284748780-19d75b9d0-d603-f424-e053-dadaa90a57ceThese highlights do not include all the information needed to use GABAPENTIN safely and effectively. See full prescribing information for GABAPENTIN. GABAPENTIN capsules, for oral use GABAPENTIN tablets, for oral use Initial U.S. Approval: 1993
71610-069-922020-01-31C16284748780-19d75b9d0-d603-f424-e053-dadaa90a57ceThese highlights do not include all the information needed to use GABAPENTIN safely and effectively. See full prescribing information for GABAPENTIN. GABAPENTIN capsules, for oral use GABAPENTIN tablets, for oral use Initial U.S. Approval: 1993

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
71610-069-45gabapentin45 in 1 BOTTLETABLET, FILM COATED452
71610-069-60gabapentin90 in 1 BOTTLETABLET, FILM COATED902
71610-069-80gabapentin180 in 1 BOTTLETABLET, FILM COATED1802
71610-069-92gabapentin270 in 1 BOTTLETABLET, FILM COATED2702

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
71610-069-45EA - Each71610-069f6d39c8a-9dec-4681-a7c7-08555812e67e12021-04-08
71610-069-60EA - Each71610-069150bf377-f98d-4330-9fa4-fbc932df2c9912018-08-13
71610-069-80EA - Each71610-0695e3f9af8-e658-4484-b0a1-254be28f51bf12018-08-13
71610-069-92EA - Each71610-069ddf3397c-0bca-4251-a98a-9a9d7bed0bab12018-08-13

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
71610-069GABAPENTIN TABLET, FILM COATED [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC]2Current NDC, Legacy NDC, 4 package rows20210323_7790d906-af26-4e60-bc6f-e906ec03cc24.zip

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
310433gabapentin 600 MG Oral TabletPSN7790d906-af26-4e60-bc6f-e906ec03cc242
310433gabapentin 600 MG Oral TabletSCD7790d906-af26-4e60-bc6f-e906ec03cc242

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionMarketing startMarketing endSampleExclude flagStatus
71610-069-457161000694545 TABLET, FILM COATED in 1 BOTTLE (71610-069-45) 2021-02-260000-00-00NoNoCurrent
71610-069-607161000696090 TABLET, FILM COATED in 1 BOTTLE (71610-069-60) 2018-05-150000-00-00NoNoCurrent
71610-069-8071610006980180 TABLET, FILM COATED in 1 BOTTLE (71610-069-80) 2018-05-150000-00-00NoNoCurrent
71610-069-9271610006992270 TABLET, FILM COATED in 1 BOTTLE (71610-069-92) 2018-05-150000-00-00NoNoCurrent